Why is PharmaResources (Shanghai) Co., Ltd ?
1
Poor Management Efficiency with a low ROCE of 5.27%
- The company has been able to generate a Return on Capital Employed (avg) of 5.27% signifying low profitability per unit of total capital (equity and debt)
2
Poor long term growth as Net Sales has grown by an annual rate of 11.68% and Operating profit at -27.24% over the last 5 years
3
With a growth in Net Profit of 98.59%, the company declared Very Positive results in Mar 26
- The company has declared positive results for the last 5 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at CNY 173.99 MM
- ROCE(HY) Highest at 4.44%
- RAW MATERIAL COST(Y) Fallen by -47.18% (YoY)
4
With ROE of 2.95%, it has a very attractive valuation with a 2.40 Price to Book Value
- Over the past year, while the stock has generated a return of 9.53%, its profits have risen by 53.1% ; the PEG ratio of the company is 1.5
- At the current price, the company has a high dividend yield of 0.7
How much should you hold?
- Overall Portfolio exposure to PharmaResources (Shanghai) Co., Ltd should be less than 10%
- Overall Portfolio exposure to Miscellaneous should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Miscellaneous)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is PharmaResources (Shanghai) Co., Ltd for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
PharmaResources (Shanghai) Co., Ltd
9.53%
0.77
65.44%
China Shanghai Composite
16.78%
1.20
13.96%
Quality key factors
Factor
Value
Sales Growth (5y)
11.68%
EBIT Growth (5y)
-27.24%
EBIT to Interest (avg)
10.31
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.28
Sales to Capital Employed (avg)
0.53
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
148.42%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
5.27%
ROE (avg)
3.33%
Valuation Key Factors 
Factor
Value
P/E Ratio
81
Industry P/E
Price to Book Value
2.40
EV to EBIT
89.24
EV to EBITDA
30.77
EV to Capital Employed
2.86
EV to Sales
3.22
PEG Ratio
1.53
Dividend Yield
0.70%
ROCE (Latest)
3.21%
ROE (Latest)
2.95%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Sideways
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Technical Movement
15What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 173.99 MM
ROCE(HY)
Highest at 4.44%
RAW MATERIAL COST(Y)
Fallen by -47.18% (YoY
PRE-TAX PROFIT(Q)
Highest at CNY 14.5 MM
NET PROFIT(Q)
Highest at CNY 13.27 MM
EPS(Q)
Highest at CNY 0.17
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for PharmaResources (Shanghai) Co., Ltd
Operating Cash Flow
Highest at CNY 173.99 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Pre-Tax Profit
Highest at CNY 14.5 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Pre-Tax Profit
At CNY 14.5 MM has Grown at 56.14%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Net Profit
Highest at CNY 13.27 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
EPS
Highest at CNY 0.17
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (CNY)
Raw Material Cost
Fallen by -47.18% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales






